E. coli-mediated siRNA silencing of Avian influenza in chickens

A technology of Escherichia coli and influenza, applied in the field of siRNA composition

Inactive Publication Date: 2021-02-26
COLORADO STATE UNIV RES FOUND
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, growing evidence of the emergence of drug-resistant AIV variants raises the risk of using drug therapies such as amantadine, rimantadine, and oseltamivir

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • E. coli-mediated siRNA silencing of Avian influenza in chickens
  • E. coli-mediated siRNA silencing of Avian influenza in chickens
  • E. coli-mediated siRNA silencing of Avian influenza in chickens

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047]Example 1-Design of siRNA and use of virus-specific siRNA to suppress avian influenza in avian tissue models

[0048]Avian influenza virus (AIV) is the most significant economic threat to poultry worldwide. AIV vaccines are limited, which highlights the need to consider new prevention strategies that can protect poultry against outbreaks. Appropriate avian tissue transfection and AIV infection models have been developed. This avian model was used to demonstrate the antiviral potential of small interfering RNA ("siRNA") targeting the two key AIV genes NP and PA required for viral replication. Chicken LMH cells were transfected with siRNA targeting NP and PA mRNA and the cells were infected with two different LPAI subtypes H8N4 and H6N2. Multivariate linear regression analysis with day as the control variable revealed a significant difference in corrected mean shedding titers between samples treated with siRNA and those untreated samples (p<0.05). The mixture of each siRNA and the ...

Embodiment 2

[0070]Example 2-Using unique RNAi delivery technology to inhibit avian influenza replication in a chicken cell model

[0071]The economic rewards of vaccinating poultry against AIV are low and are often attributed to several limitations of the vaccine. These restrictions and lack of incentives have created obvious obstacles to the effective control of AIV outbreaks in poultry. The development of new anti-influenza technologies is a key step for effectively managing and controlling the spread of this disease in poultry, minimizing financial losses, and reducing the risk of spreading to other animals (including humans). The application of RNAi methods to develop alternative antiviral drugs against AIV is a possibility. However, the delivery of RNAi mediators is still an obstacle that limits its clinical application. Transkingdom RNAi (tkRNAi) uses non-pathogenic bacteria to produce siRNA and deliver siRNA to target tissues, and may be the key to obtaining the clinical application of the ...

Embodiment 3

[0097]Example 3-Preventive treatment of chicken flocks with anti-AIV vectors

[0098]In the face of an AIV outbreak, several factors are critical to effectively control the spread of the virus among and among poultry. They include the speed with which control methods or vaccines are applied, how quickly preventive work is protective, and the ability to defend against any subtype or strain of AIV. The development of powerful poultry anti-flu technology is a key step to effectively manage and control the spread of this disease throughout the world. Previous work has proved the value of using novel anti-AIV vectors targeting the virus NP and PA genes to reduce virus shedding titers in vitro, but it has yet to be tested in vivo using experimentally challenged chickens. First use a vector with a fluorescent red protein label for visualization to assess the uptake of the vector into the chicken respiratory tissue. Once carrier uptake was demonstrated in chickens and there was no carrier-rela...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Products and associated methods are described for the delivery of one or more small interfering RNAs (siRNAs) to an avian cell using a nonpathogenic bacterium for the prevention or treatment of AvianInfluenza Virus (AIV). The siRNA is complementary to an mRNA of the AIV NP or PA sequence. In challenge studies with chickens, the siRNA is shown to prevent the onset of clinical symptoms or reduce the severity of disease, including reducing viral titers or virus shedding.

Description

[0001]This application is a PCT international patent application PCT / US2015 / 012704 with the filing date of January 23, 2015. The Chinese patent application number 201580011665.5 entered the Chinese national phase, and the invention title is "E. coli-mediated siRNA silencing of chicken and bird flu" Divisional application.[0002]Cross reference of related applications[0003]This application claims the benefits of U.S. Provisional Application No. 61 / 930,821 filed on January 23, 2014 and U.S. Provisional Application No. 61 / 986,033 filed on April 29, 2014.Technical field[0004]The present invention relates to compositions and methods for treating or preventing avian influenza in poultry. More specifically, the present invention relates to siRNA compositions that interfere with the replication of avian influenza viruses in chickens and other poultry.Background technique[0005]Avian influenza virus (AIV) is a viral disease that infects specific tissues, including respiratory, digestive and / or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/21C12N15/113A61K48/00A61K31/713A61P31/16C12R1/19
CPCC12N15/1131C12N2310/14C12N2310/531C12N2320/32C12N2330/51C12N2760/16111A61K31/7105A61P11/00A61K48/0075C12N15/113C12N15/70C12N2320/31
Inventor 林德齐·M·林可莫·D·萨尔曼杰弗里·维鲁兹
Owner COLORADO STATE UNIV RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap